These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 18368303

  • 21. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.
    Isaacson SH, Skettini J.
    Vasc Health Risk Manag; 2014; 10():169-76. PubMed ID: 24729712
    [Abstract] [Full Text] [Related]

  • 22. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
    Kuritzky L, Espay AJ, Gelblum J, Payne R, Dietrich E.
    Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731
    [Abstract] [Full Text] [Related]

  • 23. Droxidopa (Northera) for neurogenic orthostatic hypotension.
    Med Lett Drugs Ther; 2015 Jun 22; 57(1471):92-3. PubMed ID: 26079764
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Acute pandysautonomia: mass spectrometric and histopathological studies of the sympathetic nervous system during long term L-threo-3,4-dihydroxyphenylserine treatment.
    Ushiyama M, Ikeda S, Suzuki T, Yazawa M, Yanagisawa N, Tsujino S.
    J Neurol Neurosurg Psychiatry; 1996 Jul 22; 61(1):99-102. PubMed ID: 8676171
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. L-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy.
    Gibbons CH, Vernino SA, Kaufmann H, Freeman R.
    Neurology; 2005 Oct 11; 65(7):1104-6. PubMed ID: 16217067
    [Abstract] [Full Text] [Related]

  • 28. Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients.
    McDonell KE, Preheim BA, Diedrich A, Muldowney JAS, Peltier AC, Robertson D, Biaggioni I, Shibao CA.
    J Clin Hypertens (Greenwich); 2019 Sep 11; 21(9):1308-1314. PubMed ID: 31368635
    [Abstract] [Full Text] [Related]

  • 29. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A).
    Hauser RA, Hewitt LA, Isaacson S.
    J Parkinsons Dis; 2014 Sep 11; 4(1):57-65. PubMed ID: 24326693
    [Abstract] [Full Text] [Related]

  • 30. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B).
    Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G.
    Mov Disord; 2015 Apr 15; 30(5):646-54. PubMed ID: 25487613
    [Abstract] [Full Text] [Related]

  • 31. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.
    Chen JJ, Han Y, Tang J, Portillo I, Hauser RA, Dashtipour K.
    Ann Pharmacother; 2018 Dec 15; 52(12):1182-1194. PubMed ID: 29972032
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure.
    Goldstein DS, Holmes C, Kaufmann H, Freeman R.
    Clin Auton Res; 2004 Dec 15; 14(6):363-8. PubMed ID: 15666063
    [Abstract] [Full Text] [Related]

  • 36. Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report.
    Mobarek SK.
    BMC Cardiovasc Disord; 2020 Feb 04; 20(1):54. PubMed ID: 32019498
    [Abstract] [Full Text] [Related]

  • 37. Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.
    Goodman BP, Gupta F.
    Clin Auton Res; 2017 Jul 04; 27(Suppl 1):21-23. PubMed ID: 28631222
    [No Abstract] [Full Text] [Related]

  • 38. Dopamine B hydroxylase deficiency responsible for severe dysautonomic orthostatic hypotension in an elderly patient.
    Gentric A, Fouilhoux A, Caroff M, Mottier D, Jouquan J.
    J Am Geriatr Soc; 1993 May 04; 41(5):550-1. PubMed ID: 8486891
    [Abstract] [Full Text] [Related]

  • 39. Droxidopa approved for neurogenic orthostatic hypotension.
    Traynor K.
    Am J Health Syst Pharm; 2014 Apr 01; 71(7):520. PubMed ID: 24644107
    [No Abstract] [Full Text] [Related]

  • 40. Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension.
    Elgebaly A, Abdelazeim B, Mattar O, Gadelkarim M, Salah R, Negida A.
    Clin Auton Res; 2016 Jun 01; 26(3):171-80. PubMed ID: 26951135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.